1-20 of 45
acute lymphocytic leukemia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Physiologic IGFBP7 levels prolong IGF1R activation in acute lymphoblastic leukemia

Leonardo Luís Artico, Angelo Brunelli Albertoni Laranjeira, Livia Weijenborg Campos, Juliana Ronchi Corrêa, Priscila Pini Zenatti, José Barreto Campello Carvalheira, Sandra Regina Brambilla, Alexandre Eduardo Nowill, Silvia Regina Brandalise, José Andrés Yunes
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3633–3646.
https://doi.org/10.1182/bloodadvances.2020003627
Published: 2021
Includes: Supplemental data
Journal Articles

Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia

Clinical Trials & Observations
Hasmukh Jain, Manju Sengar, Vasu Babu Goli, Jayashree Thorat, Prashant Tembhare, Dhanlaxmi Shetty, V. N. Avinash Bonda, Lingaraj Nayak, P. G. Subramanian, Bhausaheb Bagal, Nikhil Patkar, Neha Sharma, Himanshi Gupta, Sumeet Gujral
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3436–3444.
https://doi.org/10.1182/bloodadvances.2020003368
Published: 2021
Journal Articles

IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial

Rachel J. Mitchell, Amy A. Kirkwood, Emilio Barretta, Laura Clifton-Hadley, Emma Lawrie, SooWah Lee, Daniel Leongamornlert, David I. Marks, Andrew K. McMillan, Tobias F. Menne, Elli Papaemmanuil, Bela Patel, Pip Patrick, Clare J. Rowntree, Nahid Zareian, Krisztina Zuborne Alapi, Anthony V. Moorman, Adele K. Fielding
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3322–3332.
https://doi.org/10.1182/bloodadvances.2021004430
Published: 2021
Includes: Supplemental data
Journal Articles

Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia

Clinical Trials & Observations
Lori Muffly, Vandana Sundaram, Connie Chen, Ilana Yurkiewicz, Eric Kuo, Sarah Burnash, Jay Y. Spiegel, Sally Arai, Matthew J. Frank, Laura J. Johnston, Robert Lowsky, Everett H. Meyer, Robert S. Negrin, Andrew R. Rezvani, Surbhi Sidana, Parveen Shiraz, Judith A. Shizuru, Wen-Kai Weng, Michaela Liedtke, Hyma T. Vempaty, David B. Miklos
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3147–3151.
https://doi.org/10.1182/bloodadvances.2021004234
Published: 2021
Includes: Supplemental data
Journal Articles

Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma

Clinical Trials & Observations
Xinjie Xu, Christian N. Paxton, Robert J. Hayashi, Kimberly P. Dunsmore, Stuart S. Winter, Stephen P. Hunger, Naomi J. Winick, William L. Carroll, Mignon L. Loh, Meenakshi Devidas, Thomas G. Gross, Catherine M. Bollard, Sherrie L. Perkins, Rodney R. Miles
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2890–2900.
https://doi.org/10.1182/bloodadvances.2021004334
Published: 2021
Includes: Supplemental data
Journal Articles

Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency

Clinical Trials & Observations
Sandheeah Ramdeny, Asima Chaudhary, Austen Worth, Sara Ghorashian, Mary Slatter, Su Han Lum, Ajay Vora
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2153–2155.
https://doi.org/10.1182/bloodadvances.2021004284
Published: 2021
Journal Articles

Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial

Clinical Trials & Observations
Etan Orgel, Celia Framson, Rubi Buxton, Jiyoon Kim, Gang Li, Jonathan Tucci, David R. Freyer, Weili Sun, Matthew J. Oberley, Christina Dieli-Conwright, Steven D. Mittelman
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1853–1861.
https://doi.org/10.1182/bloodadvances.2020004018
Published: 2021
Includes: Supplemental data
Journal Articles

Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia

Pablo Iglesias, Ann-Christin Puller, Marcos Seoane, Michael Spohn, Sabine Raasch, Marianne Klokow, Jürgen Müller, Lia Burkhardt, Daniela Indenbirken, Martin A. Horstmann
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1209–1223.
https://doi.org/10.1182/bloodadvances.2020001844
Published: 2021
Includes: Supplemental data
Journal Articles

Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol

Clinical Trials & Observations
Akhil Rajendra, Hasmukh Jain, V. N. Avinash Bonda, Lingaraj Nayak, Prashant Tembhare, Dhanlaxmi Shetty, Jayashree Thorat, Hemani Jain, Papagudi Ganesan Subramanian, Nikhil Patkar, Gaurav Chatterjee, Navin Khattry, Anant Gokarn, Sachin Punatar, Smruti Mokal, Bhausaheb Bagal, Manju Sengar
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1178–1193.
https://doi.org/10.1182/bloodadvances.2020003526
Published: 2021
Includes: Supplemental data
Journal Articles

Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia

Clinical Trials & Observations
Lia Phillips, Jovana Pavisic, Dominder Kaur, N. Valerio Dorrello, Larisa Broglie, Nobuko Hijiya
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4358–4361.
https://doi.org/10.1182/bloodadvances.2020002745
Published: 2020
Journal Articles

CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia

Anthony Quagliano, Anilkumar Gopalakrishnapillai, E. Anders Kolb, Sonali P. Barwe
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4393–4405.
https://doi.org/10.1182/bloodadvances.2020001592
Published: 2020
Includes: Supplemental data
Journal Articles

Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemia

Clinical Trials & Observations
Ryan D. Cassaday, Kelsey-Leigh A. Garcia, Jonathan R. Fromm, Mary-Elizabeth M. Percival, Cameron J. Turtle, Paul T. Nghiem, Phillip A. Stevenson, Elihu H. Estey
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3239–3245.
https://doi.org/10.1182/bloodadvances.2020002403
Published: 2020
Includes: Supplemental data
Journal Articles

ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia

Kayleigh M. Gallagher, Justine E. Roderick, Shi Hao Tan, Tze King Tan, Leonard Murphy, Jun Yu, Rui Li, Kevin W. O’Connor, Julie Zhu, Michael R. Green, Takaomi Sanda, Michelle A. Kelliher
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3154–3168.
https://doi.org/10.1182/bloodadvances.2020001555
Published: 2020
Includes: Supplemental data
Journal Articles

Blinatumomab consolidation and maintenance therapy in adults with relapsed/refractory B-precursor acute lymphoblastic leukemia

Clinical Trials & Observations
Alessandro Rambaldi, Francoise Huguet, Pavel Zak, Paul Cannell, Qui Tran, Janet Franklin, Max S. Topp
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1518–1525.
https://doi.org/10.1182/bloodadvances.2019000874
Published: 2020
Includes: Supplemental data
Journal Articles

Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia

Clinical Trials & Observations
Michael R. Verneris, Jeffrey S. Miller, Katherine C. Hsu, Tao Wang, Jennifer A. Sees, Sophie Paczesny, Hemalatha Rangarajan, Dean A. Lee, Stephen R. Spellman, Stephanie J. Lee
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1350–1356.
https://doi.org/10.1182/bloodadvances.2019001284
Published: 2020
Journal Articles

Germline variants in predisposition genes in children with Down syndrome and acute lymphoblastic leukemia

Peleg Winer, Ivo S. Muskens, Kyle M. Walsh, Ajay Vora, Anthony V. Moorman, Joseph L. Wiemels, Irene Roberts, Anindita Roy, Adam J. de Smith
Journal: Blood Advances
Blood Adv (2020) 4 (4): 672–675.
https://doi.org/10.1182/bloodadvances.2019001216
Published: 2020
Includes: Supplemental data
Journal Articles

Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemia

Clinical Trials & Observations
Richard C. Harvey, Sarah K. Tasian
Journal: Blood Advances
Blood Adv (2020) 4 (1): 218–228.
https://doi.org/10.1182/bloodadvances.2019000163
Published: 2020
Journal Articles

Clinical response to larotrectinib in adult Philadelphia chromosome–like ALL with cryptic ETV6-NTRK3 rearrangement

Clinical Trials & Observations
Valentina Nardi, Nora Ku, Matthew J. Frigault, Adrian M. Dubuc, Harrison Kwei Tsai, Philip C. Amrein, Gabriela S. Hobbs, Andrew M. Brunner, Rupa Narayan, Meghan E. Burke, Julia Foster, Paola Dal Cin, Marcela V. Maus, Amir T. Fathi, Hanno Hock
Journal: Blood Advances
Blood Adv (2020) 4 (1): 106–111.
https://doi.org/10.1182/bloodadvances.2019000769
Published: 2020
Includes: Supplemental data
Journal Articles

Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes

Clinical Trials & Observations
Caner Saygin, Ashwin Kishtagari, Ryan D. Cassaday, Natalie Reizine, Ilana Yurkiewicz, Michaela Liedtke, Wendy Stock, Richard A. Larson, Ross L. Levine, Martin S. Tallman, Jae H. Park, Cassandra Kerr, Bartlomiej Przychodzen, Mikkael A. Sekeres, Matt E. Kalaycio, Hetty E. Carraway, Betty K. Hamilton, Ronald Sobecks, Aaron Gerds, Sudipto Mukherjee, Aziz Nazha, Jaroslaw P. Maciejewski, Anjali S. Advani
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4228–4237.
https://doi.org/10.1182/bloodadvances.2019000925
Published: 2019
Includes: Supplemental data
Journal Articles

Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity

Clinical Trials & Observations
Franziska Schramm, Udo zur Stadt, Martin Zimmermann, Norbert Jorch, Arnulf Pekrun, Arndt Borkhardt, Thomas Imschweiler, Holger Christiansen, Jörg Faber, Irene Schmid, Tobias Feuchtinger, Gerhard Beron, Monique L. den Boer, Rob Pieters, Martin A. Horstmann, Gritta E. Janka-Schaub, Gabriele Escherich
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3688–3699.
https://doi.org/10.1182/bloodadvances.2019000576
Published: 2019
Includes: Supplemental data